Rhamnocitrin has been shown to increase PPAR-γ activity and inhibit the TGF-β1/Smad pathway in the ovaries of PCOS rats, ameliorating ovarian fibrosis [111]. Here, TGFB1 is linked to polycystic ovary syndrome.